YARW insider filings
Yarrow Bioscience, Inc. — 8 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-30. Screen YARW transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Alford Rachael — Chief Operating Officer | 1 | — | — | 1 |
| Frey Rebecca — Chief Executive Officer, Director | 1 | — | — | 1 |
| Payton Lori — Chief Development Officer | 1 | — | — | 1 |
| Ryder Steven — Chief Medical Officer | 1 | — | — | 1 |
| Zeronda Tyler — Chief Financial Officer | 1 | — | — | 1 |
Recent insider filings — Yarrow Bioscience, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-30 | 4 | Payton Lori — Chief Development Officer | Grant/award (A): 99,827 (derivative) @ $0 | EDGAR |
| 2026-10-30 | 4 | Ryder Steven — Chief Medical Officer | Grant/award (A): 113,137 (derivative) @ $0 | EDGAR |
| 2026-10-30 | 4 | Frey Rebecca — Chief Executive Officer, Director | Grant/award (A): 465,857 (derivative) @ $0 | EDGAR |
| 2026-10-30 | 4 | Alford Rachael — Chief Operating Officer | Grant/award (A): 89,844 (derivative) @ $0 | EDGAR |
| 2026-10-30 | 4 | Zeronda Tyler — Chief Financial Officer | Grant/award (A): 156,115 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | RTW Fund Group GP, LLC — 10% owner WONG RODERICK — 10% owner | Other (J): 133,290 @ $0 · Other (J): 133,290 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Ashiya Mona — Director | Grant/award (A): 15,435 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Zeronda Tyler — Director | Grant/award (A): 185,798 (derivative) @ $0 | EDGAR |
Recent 8-K events — Yarrow Bioscience, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K/A | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-21 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-07-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=YARW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs